Project Grant HT94252410482
Award Date 8/1/24
Completion Date 7/31/27
Dollars Obligated $486K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Centre Hospitalier Universitaire Vaudois (CHUV) a $1.184 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. This award supports the development of a clinical-grade spinal cord neuroprosthesis designed to alleviate locomotor deficits in individuals with Parkinson's disease. The research is being conducted at CHUV's facilities in...
- Summary The Defense Health Agency awarded The Research Institute of the McGill University Health Centre a $587,973 Project Grant effective August 1, 2025, through July 31, 2028, under the Military Medical Research and Development program (CFDA 12.420). The award supports research and development of discreet and wearable microwave sensing technology for continuous real-time bladder monitoring. This initiative represents an innovative medical device development effort aligned with the program's...
- The University of Ottawa received a $200,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2027. The project titled "Deciphering the Mechanism and Efficacy of Histone Deacetylase Inhibitors for Treating ADNP Syndrome" will deliver hypothesis-driven biomedical research services focused on understanding and evaluating therapeutic approaches for ADNP...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,257,982 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded August 1, 2025, with a completion date of July 31, 2028. The project, titled "Mapping the RNA Splicing Landscape of NF1 and Its Impact on Neurofibromin Function Across Tissues," supports advanced biomedical research focused on understanding RNA...
- Federal Project Grant Award Summary The University of Manitoba received a $249,823 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2027. The research project, titled "Polygenicity of Brain and Physical Reserve in Multiple Sclerosis," will be conducted at the university's facility in Ottawa, Ontario, Canada. This award supports hypothesis-driven biomedical...
- Federal Project Grant Award Summary The University of British Columbia received a $426,154 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2027. The grant supports research investigating ASCL1-driven immunological landscapes in neuroendocrine prostate cancer, with the objective of enhancing immunotherapy efficacy. This research falls within the DHA's broader mission to...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $490,602 Project Grant to Ecole Polytechnique Federale De Lausanne (EPFL) effective September 1, 2025, through August 31, 2028, under the Military Medical Research and Development program (CFDA 12.420). This award supports the development of a clinical-grade spinal cord neuroprosthesis designed to alleviate locomotor deficits in individuals with Parkinson's disease. The research will be conducted at EPFL's facilities in...
- Federal Project Grant Award Summary The University of Ottawa received a $299,760 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 15, 2025, with completion targeted for August 14, 2027. The award funds research focused on harnessing innate lymphoid cells to enhance immunotherapy efficacy in ovarian cancer treatment. This research initiative represents a translational investigation designed to...
- The University Health Network (UHN) in Toronto, Canada was awarded a $303,156 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct a study on "LINEAGE TRACING IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS AND PLEXIFORM NEUROFIBROMAS TO ASSESS TUMORAL HETEROGENEITY AND MECHANISMS OF DRUG RESISTANCE". The award, which runs from June 1, 2024 to May 31, 2026, will support UHN's cutting-edge biomedical research focused...
- Summary of Federal Project Grant Award The University Health Network (UHN), operating as Toronto General And Western Hospital Foundation, received a $213,501 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The award, effective October 1, 2025, through September 30, 2027, supports research to identify molecular biomarkers for invasive glioblastoma cell states and tumor microenvironment modulation. UHN will deliver...